Autoimmune Diseases

GlycoEra Secures $130 Million in Series B Funding to Advance Autoimmune Disease Treatments

GlycoEra Secures $130 Million in Series B Funding to Advance Autoimmune Disease Treatments

GlycoEra AG, a Swiss biotech firm, has raised $130 million in a Series B funding round led by Novo Holdings, with participation from several new and existing investors, to advance its innovative treatments for autoimmune diseases.

June 3, 2025
Women with Autoimmune Diseases Face Higher Cardiovascular Death Risk

Women with Autoimmune Diseases Face Higher Cardiovascular Death Risk

A new study reveals that women with common autoimmune diseases like rheumatoid arthritis, lupus, and systemic sclerosis experience significantly higher cardiovascular disease-related mortality rates compared to men, highlighting critical gender disparities in health outcomes.

May 6, 2025